Comparison of immunomodulatory treatments for multiple sclerosis

被引：1
|
作者：
Durelli, L [1 ]
Clerico, M [1 ]
机构：
[1] Univ Turin, Turin, Italy
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2005年 / 12卷 / 11期
关键词：
CONSORT guidelines; glatiramer acetate; immunomodulatory treatment; interferon-beta; multiple sclerosis; randomized controlled trials;
D O I：
10.1111/j.1468-1331.2005.01372.x
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：915 / 915
页数：1
相关论文
共 50 条
  • [1] Comparison of immunomodulatory treatments for multiple sclerosis - Reply
    Haas, J
    EUROPEAN JOURNAL OF NEUROLOGY, 2005, 12 (11) : 916 - 916
  • [2] On cancer incidence in multiple sclerosis and effects of immunomodulatory treatments
    Feigin, PD
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 92 (02) : 197 - 197
  • [3] Cancer incidence in multiple sclerosis and effects of immunomodulatory treatments
    Achiron, A
    Barak, Y
    Gail, M
    Mandel, M
    Pee, D
    Ayyagari, R
    Rotstein, Z
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 89 (03) : 265 - 270
  • [4] Cancer incidence in multiple sclerosis and effects of immunomodulatory treatments
    Anat Achiron
    Yoram Barak
    Mitchell Gail
    Matilda Mandel
    David Pee
    Rajeev Ayyagari
    Zeev Rotstein
    Breast Cancer Research and Treatment, 2005, 89 : 265 - 270
  • [5] On cancer incidence in multiple sclerosis and effects of immunomodulatory treatments
    Paul D. Feigin
    Breast Cancer Research and Treatment, 2005, 92 : 197 - 197
  • [6] Immunomodulatory treatments in multiple sclerosis modify patients gut microbiota
    Gorostidi-Aicua, Miriam
    Chivite, Ane Otaegui
    Otaegui, David
    Romarate, Leire
    Arruti, Maialen
    Alegre, Laura Moles
    Trivino, Tamara Castillo
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 819 - 819
  • [7] Can we stop immunomodulatory treatments in secondary progressive multiple sclerosis?
    Bonenfant, J.
    Bajeux, E.
    Deburghgraeve, V.
    Le Page, E.
    Edan, G.
    Kerbrat, A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2017, 24 (02) : 237 - 244
  • [8] A Bayesian approach to the analysis of immunomodulatory treatments effect on multiple sclerosis course
    Bergamaschi, R
    Quaglini, S
    Berzuini, C
    Tonietti, S
    Candeloro, E
    Romani, A
    Persico, A
    Cosi, V
    MULTIPLE SCLEROSIS, 2004, 10 (7032): : S159 - S160
  • [9] Basic and escalating immunomodulatory treatments in multiple sclerosis: Current therapeutic recommendations
    H. Wiendl
    K. V. Toyka
    P. Rieckmann
    R. Gold
    H.-P. Hartung
    R. Hohlfeld
    Journal of Neurology, 2008, 255 : 1449 - 1463
  • [10] Halting disability progression in multiple sclerosis with immunomodulatory injectable treatments: Is it achievable?
    Fragoso, Y. D.
    Spelman, T.
    Duquette, P.
    Girard, M.
    Trojano, M.
    Izquierdo, G.
    Grammond, P.
    Lugaresi, A.
    Van Pesch, V.
    Grand'Maison, F.
    Oreja-Guevara, C.
    Iuliano, G.
    Bergamaschi, R.
    Rio, M. E.
    Bolanos, R. F.
    Terzi, M.
    Butzkueven, H.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 854 - 855
12345